Literature DB >> 28289595

Case report of a novel mutation of the EYA1 gene in a patient with branchio-oto-renal syndrome.

L Spahiu1, B Merovci1, V Ismaili Jaha1, A Batalli Këpuska1, H Jashari1.   

Abstract

Branchio-oto-renal (BOR) syndrome is an autosomal dominant disorder characterized by the coexistence of branchial cysts or fistulae, external ear malformation with pre-auricular pits or tags, hearing impairment and renal malformations. However, the presence of the main features varies in affected families. Here, we present a 16-year-old boy admitted to the Department of Nephrology at the Pediatric Clinic, University Clinical Center of Kosovo, Pristina, Republic of Kosovo because of severe renal insufficiency diagnosed 6 years ago, which progressed to end-stage renal failure. Clinical examination on readmission showed a pale, lethargic and edematous child, with auricular deformity, pre-auricular tags and pits as well as bilateral branchial fistulae. Laboratory tests revealed high blood urea nitrogen (BUN) 15.96 mmol/L and serum creatinine 633.0 µmol/L; low glomerular filtration rate (GFR) 12 mL/min./ 1.73 m2 and massive proteinuria 4+. Abdominal ultrasound showed bilateral kidney hypoplasia. A novel mutation of the EYA1 gene was confirmed. Daily hemodialysis is continuing until renal transplantation is done. This case is presented to increase awareness among general practitioners to consider BOR syndrome or other renal abnormalities in patients with branchial fistula and/ or external ear anomalies or similar findings in other family members.

Entities:  

Keywords:  Branchi-oto-renal (BOR) syndrome; Branchial fistulae; Hearing impairment; Renal insufficiency

Year:  2017        PMID: 28289595      PMCID: PMC5343337          DOI: 10.1515/bjmg-2016-0042

Source DB:  PubMed          Journal:  Balkan J Med Genet        ISSN: 1311-0160            Impact factor:   0.519


Introduction

Branchio-oto-renal (BOR) syndrome is an autosomal dominant disorder characterized by the coexistence of branchial cysts or fistulae, external ear malformation with pre-auricular pits or tags, hearing impairment and renal malformations. However, the presence of the main features varies in affected families [1]. Unilateral agenesis or unibilateral hypoplasia are the most common renal abnormalities that can lead to end-stage renal disease (ESRD). We here present a 16-year-old boy with ESRD from a Kosovar family with BOR syndrome.

Case Report

A 16-year-old boy was admitted to the Department of Nephrology at the Pediatric Clinic, University Clinical Center of Kosovo, Pristina, Republic of Kosovo because of severe renal insufficiency diagnosed 6 years ago. At that time, surgical correction of bilateral branchial cysts and fistulae at the Ear, Nose and Throat Department, University Clinical Center of Kosovo, Pristina, Republic of Kosovo, was planned. As laboratory evaluation revealed high serum creatinine levels, the patient was referred to our department and renal insufficiency was diagnosed. However, the parents refused hospitalization, thus we did not have any information on the patient until now. Clinical examination on readmission showed a pale, lethargic and edematous child, with auricular pinnae deformity, pre-auricular tags and pits as well as bilateral branchial fistulae as shown in Figures 1 and 2. His weight was 71 kg and height 163 cm.
Figure 1

Auricular pinnae deformity with pre-auricular pit and tag (circled).

Figure 2

Bilateral branchial fistulae.

Auricular pinnae deformity with pre-auricular pit and tag (circled). Bilateral branchial fistulae. Renal ultrasound showed bilateral kidney hypoplasia (Figure 3). In addition, bilateral fistulae were noticed in the neck of the patient (Figure 2), and the ultrasound of neck structures found communicating with an anechogen structure (possible puss) in the submandilar region.
Figure 3

Bilateral kidney hypoplasia.

Bilateral kidney hypoplasia. Laboratory tests were as the follows: red blood cell (RBC) count: 3.57 × 1012/L; white blood cell (WBC) count: 6.0 × 109/L; platelets: 242 × 109/L; hemoglobin (Hb): 11.0 g/dL; hematocrit or packed cell volume (PCV): 0.30 L/L; blood urea nitrogen (BUN): 15.96 mmol/L; serum creatinine: 633.0 µmol/L; total proteins: 7.47 g/dL; albumin: 5.09 g/dL; glycemia: 5.19 mmol/L; erythrocyte sedimentation rate (ESR): 40 mm/hour; C-reactive protein (CRP): 24 mg/dL; procalcitonine: 1.07 ng/mL, urinalysis revealed massive proteinuria (4+) and 24 hour protein collection was 2.738 g/24 hour. Clotting screen was normal. Glomerular filtration rate (GFR) was 12 mL/min./1.73 m2 corresponding with grade 5 of chronic kidney disease. A central venous catheter was placed and hemodialysis was initiated. Conductive hearing impairment was documented with 50-70 dB on audiogram, encountering another major phe-notypic feature. Ophthalmological examination was revealed to be normal except for small refractory errors. Furthermore, genetic analysis detected a premature stop codon (nonsense) mutation on p.Gln543* (c.1627C>T) of the EYA1 gene. It is a novel mutation that clearly causes severe damage on protein function. Phenotypic features of his father and sister are consistent with BOR syndrome and are illustrated in Figure 4. Examination of other members of the family was attempted but we could not acquire their consent. Renal transplantation is planned. Until then, the patient is receiving hemodialysis on a daily basis.
Figure 4

Family pedigree of the patient. Presence or absence of the four main features of BOR syndrome are marked by numbers. 1: Pre-auricular pits; 2: hearing loss; 3: branchial fistulae; 4: renal abnormalities.

Family pedigree of the patient. Presence or absence of the four main features of BOR syndrome are marked by numbers. 1: Pre-auricular pits; 2: hearing loss; 3: branchial fistulae; 4: renal abnormalities.

Discussion

The incidence of BOR is estimated between 1:40,000 to 1:700,000. However, the incidence is higher among deaf children [2]. Fraser et al. [3] reported that 2.0% of deaf patients and 6.0% of ESRD patients have genetically proven BOR syndrome. Furthermore, more than 80 disorders presenting with sensorineural deafness and renal disturbances have been reported. Thus, phenotypic criteria should often be complemented with genetic analysis to avoid misdiagnosis. Major phenotypic anomalies that occur in more than 20.0% of patients are: sensorineural or mixed hearing impairment (95.4%), followed by malformed auricles (86.8%), second branchial arch fistula/cyst (86.5%), pre-auricular sinus (87.0%), and renal anomalies ranging from mild hypoplasia to complete absence (58.3%) [4]. In addition, phenotypic anomalies occurring in less than 20.0% of patients are considered minor, i.e., pre-auricular tags, lacrimal duct aplasia, retrognathia, short palate, palatoschisis, facial paralysis, meatal atresia, etc. Likewise, at least three major criteria or two major and two minor criteria or one major criteria plus an affected first degree relative must be fulfilled to meet the clinical criteria for a BOR syndrome diagnosis [5]. Branchial fistulae, pre-auricular tags and conductive hearing impairment were present in all three members of the presented family. Also, renal abnormalities in the form of unilateral hypoplasia (father and sister) and bilateral hypoplasia (our patient) corresponding with BOR syndrome diagnosis were confirmed. However, variable phenotypic expressivity within families due to reduced penetrance has been observed [6]. Pierides et al. [1] followed 20 members of a three-generation Greek-Cypriot family for nearly three decades, and found only four members manifesting with all four BOR syndrome features of brachial fistulae, hearing loss, pre-auricular pits and renal abnormalities leading to renal failure. In 1992, the BOR gene was mapped to chromosome 8q12-22 [7]. Five years later, the BOR gene was identified as the human homologue of the Drosophila eyes absent gene (eya) and called it EYA1 [8]. However, mutations and deletions of the EYE1 gene have been identified in only about 40.0% of individuals with the BOR phenotype. Mutations of other genes such as SIX1 and SIX5 have also been related to BOR syndrome, but at a much lower incidence [9-11]. At least 80 mutations of the EYE1 gene resulting in BOR syndrome [12], suggests that the type of mutation has a dosage effect, explaining the variable ex-pressivity within families. Further studies are needed to better understand the phenotypical expressivity of BOR syndrome. Branchial anomalies account for up to 45.0% of neck pathologies. It is usually the main complaint that families seek medical attention for [13]. Hence, BOR syndrome should always be considered in patients with branchial fistula and/or external ear anomalies or similar findings in other family members.
  13 in total

1.  Branchio-oto-renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR.

Authors:  Dana J Orten; Stephanie M Fischer; Jessica L Sorensen; Uppala Radhakrishna; Cor W R J Cremers; Henri A M Marres; Guy Van Camp; Katherine O Welch; Richard J H Smith; William J Kimberling
Journal:  Hum Mutat       Date:  2008-04       Impact factor: 4.878

2.  A family with the branchio-oto-renal syndrome: clinical and genetic correlations.

Authors:  Alkis M Pierides; Yiannis Athanasiou; Kyproula Demetriou; Michael Koptides; C Constantinou Deltas
Journal:  Nephrol Dial Transplant       Date:  2002-06       Impact factor: 5.992

3.  The presence of a widened vestibular aqueduct and progressive sensorineural hearing loss in the branchio-oto-renal syndrome. A family study.

Authors:  C Stinckens; L Standaert; J W Casselman; P L Huygen; S Kumar; J Van de Wallen; C W Cremers
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2001-07-02       Impact factor: 1.675

4.  Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome.

Authors:  Bethan E Hoskins; Carl H Cramer; Derek Silvius; Dan Zou; Richard M Raymond; Dana J Orten; William J Kimberling; Richard J H Smith; Dominique Weil; Christine Petit; Edgar A Otto; Pin-Xian Xu; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2007-02-22       Impact factor: 11.025

5.  A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family.

Authors:  S Abdelhak; V Kalatzis; R Heilig; S Compain; D Samson; C Vincent; D Weil; C Cruaud; I Sahly; M Leibovici; M Bitner-Glindzicz; M Francis; D Lacombe; J Vigneron; R Charachon; K Boven; P Bedbeder; N Van Regemorter; J Weissenbach; C Petit
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

Review 6.  Renal failure and deafness: branchio-oto-renal syndrome.

Authors:  M Misra; K D Nolph
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

7.  Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences.

Authors:  Eugene H Chang; Maithilee Menezes; Nicole C Meyer; Robert A Cucci; Virginie S Vervoort; Charles E Schwartz; Richard J H Smith
Journal:  Hum Mutat       Date:  2004-06       Impact factor: 4.878

8.  SIX1 mutation screening in 247 branchio-oto-renal syndrome families: a recurrent missense mutation associated with BOR.

Authors:  Amit Kochhar; Dana J Orten; Jessica L Sorensen; Stephanie M Fischer; Cor W R J Cremers; William J Kimberling; Richard J H Smith
Journal:  Hum Mutat       Date:  2008-04       Impact factor: 4.878

9.  Autosomal dominant branchio-oto-renal syndrome--localization of a disease gene to chromosome 8q by linkage in a Dutch family.

Authors:  S Kumar; W J Kimberling; J B Kenyon; R J Smith; H A Marres; C W Cremers
Journal:  Hum Mol Genet       Date:  1992-10       Impact factor: 6.150

Review 10.  Anatomical Changes and Audiological Profile in Branchio-oto-renal Syndrome: A Literature Review.

Authors:  Tâmara Andrade Lindau; Ana Cláudia Vieira Cardoso; Natalia Freitas Rossi; Célia Maria Giacheti
Journal:  Int Arch Otorhinolaryngol       Date:  2013-11-05
View more
  2 in total

1.  Human and mouse studies establish TBX6 in Mendelian CAKUT and as a potential driver of kidney defects associated with the 16p11.2 microdeletion syndrome.

Authors:  Nan Yang; Nan Wu; Shuangshuang Dong; Ling Zhang; Yanxue Zhao; Weisheng Chen; Renqian Du; Chengcheng Song; Xiaojun Ren; Jiaqi Liu; Davut Pehlivan; Zhenlei Liu; Jia Rao; Chunyan Wang; Sen Zhao; Amy M Breman; Huadan Xue; Hao Sun; Jianxiong Shen; Shuyang Zhang; Jennifer E Posey; Hong Xu; Li Jin; Jianguo Zhang; Pengfei Liu; Simone Sanna-Cherchi; Guixing Qiu; Zhihong Wu; James R Lupski; Feng Zhang
Journal:  Kidney Int       Date:  2020-05-22       Impact factor: 10.612

2.  The first case of NSHL by direct impression on EYA1 gene and identification of one novel mutation in MYO7A in the Iranian families.

Authors:  Ehsan Razmara; Fatemeh Bitarafan; Elika Esmaeilzadeh-Gharehdaghi; Navid Almadani; Masoud Garshasbi
Journal:  Iran J Basic Med Sci       Date:  2018-03       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.